3 Key Trends to Consider for Oncology Management by Rebecca Borgert June 5, 2019Cancer, Cancer treatment, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit Drug Management, Medical Oncology Spend, Novel Cancer Drugs, Oncology, Oncology Biosimilars, Oncology Management
Do You Know the Truth about Trend? by Magellan Health Insights June 5, 2017Magellan Rx Management, Medical Pharmacy, Pharmacy Spend, Specialty, Trend
What do Employers Need to Know about Escalating Specialty Drug Spend? by Kathy Campagna May 24, 2017Autoimmune, Employers, Magellan Rx Management, Medical Benefit, Oncology, PBM, Rare Diseases, Specialty Pharmacy
Six Ways to Keep Specialty Spend Under Control by Magellan Health Insights March 31, 2017Magellan Rx Management, Matt Ward, Medical Pharmacy, Oncology, PBM, Pharmacy Benefits Management, Specialty Pharmacy
Learn More: Magellan Rx Management’s Medicaid Trend Report Webinar by Doug Brown December 6, 2016Doug Brown, Fee-for-Service, Formulary, Magellan Rx Management, Medicaid, Pharmacy
The Trends and Complexities of Provider-Administered Drugs by Kristen Reimers November 3, 2016Injectable Drugs, Magellan Rx Management, Magellan Rx Trend Report, Medical Pharmacy, Site-of-Service, Specialty Pharmacy
Part 2: Magellan Open Vision Exchange (MOVE) 2016 Recap by Gus Giraldo November 1, 2016Arizona, Barry Smith, Magellan Health, Magellan Healthcare, Magellan Rx Management, MOVE
Part 1: Magellan Open Vision Exchange (MOVE) 2016 Recap by Gus Giraldo October 27, 2016Barry Smith, crowdsourcing, Healthcare, healthcare experience, healthcare innovation, Magellan, Magellan Health, Magellan Rx Management, Mick Ebeling, MOVE, MSK, Peer Support, Scottsdale
